https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-03 / Int J Cancer 2024 Oct;155(8):1443-1454
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-03 / Int J Cancer 2024 Oct;155(8):1443-14542024-07-03 00:00:002024-07-03 00:00:00Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-3093
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-30932024-07-01 00:00:002024-07-01 00:00:00Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-31 / Int Immunopharmacol 2024 Jul;136:112305
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-31 / Int Immunopharmacol 2024 Jul;136:1123052024-05-31 00:00:002024-05-31 00:00:00Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-30 / Viruses 2024 May;16(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-30 / Viruses 2024 May;16(6)2024-05-30 00:00:002024-05-30 00:00:00The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-28 / Ann Transl Med 2024 Aug;12(4):77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-28 / Ann Transl Med 2024 Aug;12(4):772024-05-28 00:00:002025-02-25 11:37:38Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-284
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-2842024-04-21 00:00:002024-04-21 00:00:00The future of cancer vaccines against colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-15 / Cell Rep Med 2024 May;5(5):101516
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-15 / Cell Rep Med 2024 May;5(5):1015162024-04-15 00:00:002025-02-25 12:30:45Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-09 / Med Oncol 2024 Apr;41(5):112
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-09 / Med Oncol 2024 Apr;41(5):1122024-04-09 00:00:002024-04-09 00:00:00Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-28 / Biomedicines 2024 Mar;12(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-28 / Biomedicines 2024 Mar;12(4)2024-03-28 00:00:002024-04-30 08:35:31Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-21 / Front Immunol 2024;15:1375433
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-21 / Front Immunol 2024;15:13754332024-03-21 00:00:002024-03-21 00:00:00New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
